Clinical Trials

290 enrolled

Uterine Cervical Neoplasms

NCT02465736 2024-01-16

Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)

610 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT06110663 2023-11-01

A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy

314 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00411138 2023-10-11

PORTEC-3

670 enrolled

Endometrial Neoplasms

NCT06031597 2023-09-13

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

105 enrolled

Carcinoma, Non-Small-Cell Lung, Radiation Pneumonitis

NCT00632853 2023-06-12

Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

731 enrolled 11 charts

Lung Neoplasms

NCT03991403 2023-04-03

Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC

228 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03700476 2023-03-28

CONTINUUM

425 enrolled

Nasopharyngeal Neoplasms

NCT00526396 2023-03-24

STAD-1

160 enrolled

Small Cell Lung Carcinoma

NCT01405586 2023-03-24

MILES-3

299 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01656551 2023-03-24

MILES-4

232 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05766605 2023-03-13

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

90 enrolled

Hepatocellular Carcinoma Resectable

NCT05701436 2023-03-02

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

144 enrolled

Liver, Cancer of, Primary Resectable

NCT05446883 2022-11-30

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

498 enrolled

Uterine Cervical Neoplasms

NCT01855451 2022-11-18

HPVOropharynx

189 enrolled

Tumor-Agnostic

Carcinoma

NCT03837808 2022-11-07

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

384 enrolled

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

NCT04898374 2022-08-17

Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma

120 enrolled

Nasopharyngeal Carcinoma

NCT03707509 2022-07-01

Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma

263 enrolled

Nasopharyngeal Carcinoma

NCT02639650 2022-06-03

Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

214 enrolled

Gestational Trophoblastic Disease

NCT01880359 2022-05-10

AF CRT +/- Nimorazole in HNSCC

640 enrolled

Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers

NCT03366415 2022-03-04

Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

420 enrolled

Nasopharyngeal Carcinoma

NCT02607592 2022-02-25

NACA

293 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02743923 2021-12-21

Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer

203 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05132413 2021-11-24

A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer

561 enrolled

Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer

NCT00942357 2021-10-19

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

813 enrolled 14 charts

Endometrial Clear Cell Adenocarcinoma

NCT04426955 2021-09-16

Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer

396 enrolled

Esophageal Neoplasms

NCT02512315 2021-08-30

A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma

192 enrolled

Nasopharyngeal Carcinoma

NCT04961970 2021-07-14

HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC

188 enrolled

Cholangiocarcinoma

NCT02667743 2021-03-17

Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC

454 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04766359 2021-02-23

Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal Carcinoma

364 enrolled

Nasopharyngeal Carcinoma

NCT04490421 2021-02-08

Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer.

45 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01817023 2021-01-29

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

590 enrolled

Nasopharyngeal Carcinoma

NCT04568304 2020-09-29

A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

364 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT03912415 2020-09-18

FERMATA

316 enrolled

Uterine Cervical Neoplasms

NCT03912389 2020-09-17

DOMAJOR

292 enrolled

Non-Squamous Non-Small Cell Neoplasm of Lung

NCT04502641 2020-08-06

Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial

160 enrolled

Hypopharyngeal Neoplasms

NCT04414566 2020-06-04

Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

562 enrolled

Nasopharyngeal Carcinoma

NCT01993979 2020-05-04

POUT

261 enrolled

Genitourinary

Transitional Cell Carcinoma of Ureter

NCT02879513 2020-03-23

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

290 enrolled

Breast

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT02076477 2020-03-17

OITROLC

420 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03023436 2019-09-13

Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis

220 enrolled

Stomach Neoplasms

NCT01561586 2019-02-27

TACO

374 enrolled

Uterine Cervical Neoplasms

NCT03601975 2019-02-04

Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

336 enrolled

Nasopharyngeal Carcinoma

NCT03623087 2018-08-14

SIMPLE Chemotherapy for NK Lymphoma/Leukaemia

68 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Recurrence

NCT02434614 2018-05-16

Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

440 enrolled

Nasopharyngeal Carcinoma

NCT01872962 2018-04-24

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

480 enrolled

Nasopharyngeal Carcinoma

NCT02629718 2018-03-16

SYSGO-003

700 enrolled

Uterine Cervical Neoplasms

NCT03435302 2018-02-19

HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma

204 enrolled

Dermatologic

Melanoma

NCT03366883 2018-01-09

Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC

420 enrolled